These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 8573349)

  • 1. Proteolytic remodeling of extracellular matrix.
    Birkedal-Hansen H
    Curr Opin Cell Biol; 1995 Oct; 7(5):728-35. PubMed ID: 8573349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The matrix metalloproteinases and their inhibitors.
    Murphy G; Docherty AJ
    Am J Respir Cell Mol Biol; 1992 Aug; 7(2):120-5. PubMed ID: 1497900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and their inhibitors in tumor progression.
    De Clerck YA; Shimada H; Taylor SM; Langley KE
    Ann N Y Acad Sci; 1994 Sep; 732():222-32. PubMed ID: 7978795
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of matrix metalloproteinase activity.
    Murphy G; Willenbrock F; Crabbe T; O'Shea M; Ward R; Atkinson S; O'Connell J; Docherty A
    Ann N Y Acad Sci; 1994 Sep; 732():31-41. PubMed ID: 7978800
    [No Abstract]   [Full Text] [Related]  

  • 5. [Matrix metalloproteinase (MMP)].
    Hornebeck W; Lafuma C
    C R Seances Soc Biol Fil; 1991; 185(3):127-34. PubMed ID: 1835422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of tissue inhibitors of metalloproteinases (TIMPS) during matrix metalloproteinase activation.
    Nagase H; Suzuki K; Itoh Y; Kan CC; Gehring MR; Huang W; Brew K
    Adv Exp Med Biol; 1996; 389():23-31. PubMed ID: 8860990
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of matrix metalloproteinases during extracellular matrix turnover.
    Corcoran ML; Kleiner DE; Stetler-Stevenson WG
    Adv Exp Med Biol; 1995; 385():151-9; discussion 179-84. PubMed ID: 8571826
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural biochemistry and activation of matrix metalloproteases.
    Kleiner DE; Stetler-Stevenson WG
    Curr Opin Cell Biol; 1993 Oct; 5(5):891-7. PubMed ID: 8240832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases: a review.
    Birkedal-Hansen H; Moore WG; Bodden MK; Windsor LJ; Birkedal-Hansen B; DeCarlo A; Engler JA
    Crit Rev Oral Biol Med; 1993; 4(2):197-250. PubMed ID: 8435466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue inhibitors of matrix metalloproteinases in cancer.
    Blavier L; Henriet P; Imren S; Declerck YA
    Ann N Y Acad Sci; 1999 Jun; 878():108-19. PubMed ID: 10415723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
    Stracke JO; Fosang AJ; Last K; Mercuri FA; Pendás AM; Llano E; Perris R; Di Cesare PE; Murphy G; Knäuper V
    FEBS Lett; 2000 Jul; 478(1-2):52-6. PubMed ID: 10922468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease.
    Ries C; Petrides PE
    Biol Chem Hoppe Seyler; 1995 Jun; 376(6):345-55. PubMed ID: 7576228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases.
    Nagase H; Woessner JF
    J Biol Chem; 1999 Jul; 274(31):21491-4. PubMed ID: 10419448
    [No Abstract]   [Full Text] [Related]  

  • 14. Matrix metalloproteinases and their inhibitors.
    Murphy G
    Acta Orthop Scand Suppl; 1995 Oct; 266():55-60. PubMed ID: 8553862
    [No Abstract]   [Full Text] [Related]  

  • 15. Matrix vesicles produced by osteoblast-like cells in culture become significantly enriched in proteoglycan-degrading metalloproteinases after addition of beta-glycerophosphate and ascorbic acid.
    Dean DD; Schwartz Z; Bonewald L; Muniz OE; Morales S; Gomez R; Brooks BP; Qiao M; Howell DS; Boyan BD
    Calcif Tissue Int; 1994 May; 54(5):399-408. PubMed ID: 8062158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of matrix metalloproteinases in tumor cells].
    Seiki M
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):387-92. PubMed ID: 8439185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and their inhibitors in the nervous system: the good, the bad and the enigmatic.
    Campbell IL; Pagenstecher A
    Trends Neurosci; 1999 Jul; 22(7):285-7. PubMed ID: 10484748
    [No Abstract]   [Full Text] [Related]  

  • 18. Metalloproteinases and their inhibitors in matrix remodeling.
    Matrisian LM
    Trends Genet; 1990 Apr; 6(4):121-5. PubMed ID: 2132731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
    Alexander JP; Bradley JM; Gabourel JD; Acott TS
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, expression, and developmental function of early divergent forms of metalloproteinases in hydra.
    Sarras MP; Yan L; Leontovich A; Zhang JS
    Cell Res; 2002 Sep; 12(3-4):163-76. PubMed ID: 12296376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.